home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650444.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
2KB
|
39 lines
Document 0444
DOCN M9650444
TI Syringe exchange: HIV prevention, key findings, and future directions.
DT 9605
AU Paone D; Des Jarlais DC; Gangloff R; Milliken J; Friedman SR; Beth
Israel Medical Center, Chemical Dependency Institute, New; York, NY
10003, USA.
SO Int J Addict. 1995;30(12):1647-83. Unique Identifier : AIDSLINE
MED/96122207
AB HIV among injecting drug users (IDUs) has now been documented in over 60
countries in the world, and there are an additional 40 countries where
injecting drug use has been reported including widespread epidemics in
Southeast and southern Asia and in Latin America. At present HIV
infection is almost always fatal, and there is no promise that a
preventive vaccine will become available soon. Given the enormity of the
HIV epidemic among IDUs and the critical need to reduce the spread of
HIV transmission to and from IDUs, prevention efforts are essential.
Syringe-exchange programs have become a major component of HIV
prevention strategies in most developed countries and work within the
philosophy of harm reduction. Increasing access to sterile syringes has
been met with considerable controversy. Opponents of syringe exchange
have generally argued that increasing access to sterile syringes would
simultaneously increase the number of injecting drug users, increase the
frequency of injection for already active IDUs, and appear to condone an
illegal behavior. To date many research studies and four major reviews
of syringe exchange literature have been conducted. All studies thus far
have shown no increase in illicit drug injection associated with syringe
exchanges, and significant decrease in drug risk behaviors.
DE Cross-Sectional Studies Forecasting Health Services
Accessibility/TRENDS Human HIV Infections/*PREVENTION &
CONTROL/TRANSMISSION Incidence Needle-Exchange Programs/*TRENDS
Program Evaluation Substance Abuse,
Intravenous/EPIDEMIOLOGY/*REHABILITATION JOURNAL ARTICLE REVIEW
REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).